← Back to MLYS

Mineralys Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 11/08/2026Mar 2026Filed 11/08/2026Sep 2025Filed 10/11/2025Jun 2025Filed 11/08/2026Mar 2025Filed 11/08/2026Sep 2024Filed 10/11/2025Jun 2024Filed 10/11/2025Mar 2024Filed 10/11/2025
−$241−$39−$37−$43−$42−$56−$41−$32
−$2.85−$0.47−$0.52−$0.66−$0.79−$1.13−$0.83−$0.70
8583716553504945

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.